LONDON BROKER RATINGS: Berenberg raises Vodafone; Barclays cuts Hikma
(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and on Tuesday: Read More
| Price | 1,857.00p on 13-01-2026 at 13:43:22 |
|---|---|
| Change | -20.00p -1.07% |
| Buy | 1,857.50p |
| Sell | 1,856.50p |
| Last Trade: | Sell 24.00 at 1,856.50p |
| Day's Volume: | 864,188 |
| Last Close: | 1,877.00p |
| Open: | 1,868.50p |
| ISIN: | GB00BN7SWP63 |
| Day's Range | 1,854.50p - 1,874.00p |
| 52wk Range: | 1,242.50p - 1,909.50p |
| Market Capitalisation: | £74.91b |
| VWAP: | 1,860.17623p |
| Shares in Issue: | 4.03b |
Glaxosmithkline (GSK) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Sell* | 24 | 1,856.50p | SI Trade |
13:43:22 - 13-Jan-26 |
| Sell* | 286 | 1,856.50p | SI Trade |
13:43:22 - 13-Jan-26 |
| Sell* | 294 | 1,856.50p | SI Trade |
13:43:22 - 13-Jan-26 |
| Sell* | 425 | 1,856.50p | Ordinary |
13:43:11 - 13-Jan-26 |
| Sell* | 133 | 1,857.00p | Automatic Execution |
13:43:07 - 13-Jan-26 |
| Sell* | 90 | 1,857.00p | Automatic Execution |
13:43:07 - 13-Jan-26 |
| Sell* | 204 | 1,857.00p | Automatic Execution |
13:42:54 - 13-Jan-26 |
| Unknown* | 0 | 1,857.50p | SI Trade |
13:42:50 - 13-Jan-26 |
| Buy* | 2 | 1,858.00p | SI Trade |
13:42:38 - 13-Jan-26 |
| Sell* | 500 | 1,856.87p | Ordinary |
13:42:35 - 13-Jan-26 |
Glaxosmithkline (GSK) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 7th Jan 2026 7:05 am | RNS | EC approval of Shingrix PFS |
| 7th Jan 2026 7:00 am | RNS | Positive phase 3 data for GSK's bepirovirsen |
| 6th Jan 2026 7:00 am | RNS | Exdensur approved in Japan |
| 5th Jan 2026 3:30 pm | RNS | Director/PDMR Shareholding |
| 5th Jan 2026 3:00 pm | RNS | Total Voting Rights |
| 5th Jan 2026 7:00 am | RNS | Nucala for adults with COPD approved in China |
| 22nd Dec 2025 3:30 pm | RNS | Director/PDMR Shareholding |
| 22nd Dec 2025 3:30 pm | RNS | Director/PDMR Shareholding |
| 22nd Dec 2025 7:00 am | RNS | GSK to lower drug prices and expand access in US |
| 22nd Dec 2025 7:00 am | RNS | GSK to lower drug prices and expand access in US |